Belite Bio (BLTE) Operating Leases (2022 - 2025)

Belite Bio's Operating Leases history runs 4 years deep, the most recent figure standing at $188000.0 for Q4 2025.

• In Q4 2025, Operating Leases fell 27.97% year-over-year to $188000.0; the TTM figure through Dec 2025 stood at $188000.0 (down 27.97% YoY), while the FY2025 annual figure was $188000.0, down 27.97% from the prior year.
• Operating Leases for Q4 2025 stood at $188000.0, down from $245000.0 in the prior quarter.
• The five-year high for Operating Leases was $668000.0 in Q4 2022, with the low at $188000.0 in Q4 2025.
• The 4-year median for Operating Leases is $261000.0 (2024), against an average of $388000.0.
• The sharpest annual moves came in 2023 and 2024: Operating Leases slipped 13.47% in 2023, then tumbled 54.84% in 2024.
• Belite Bio's Operating Leases stood at $668000.0 in 2022, then retreated by 13.47% to $578000.0 in 2023, then sank by 54.84% to $261000.0 in 2024, then fell by 27.97% to $188000.0 in 2025.
• Business Quant data shows BLTE's Operating Leases at $188000.0 in Q4 2025, $245000.0 in Q3 2025, and $261000.0 in Q4 2024.